Bausch Health (FRA:BVF) Debt-to-Asset : 0.82 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Bausch Health Debt-to-Asset?

Bausch Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €495 Mil. Bausch Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €19,813 Mil. Bausch Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €24,760 Mil. Bausch Health's debt to asset for the quarter that ended in Mar. 2024 was 0.82.

Bausch Health Debt-to-Asset Historical Data

The historical data trend for Bausch Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Debt-to-Asset Chart

Bausch Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.77

0.78

0.81

0.82

Bausch Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.81	0.81	0.83	0.82	0.82

Competitive Comparison of Bausch Health's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bausch Health's Debt-to-Asset falls into.

Bausch Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bausch Health's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(412.65	+	20117.146)	/	25079.95
	=	0.82

Bausch Health's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(494.96	+	19813.12)	/	24759.96
	=	0.82

Bausch Health (FRA:BVF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Bausch Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bausch Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (FRA:BVF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany BHC:Canada

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (FRA:BVF) Headlines

No Headlines